Life sciences company BioRestorative Therapies has been named one of the 10 most innovative regenerative medicine companies in 2022 by Insights Care Magazine.
The company develops therapeutic products using cell and tissue protocols, mostly involving adult stem cells. Its main programs aim to treat disc and spine disease as well as metabolic disorders, according to a Jan. 26 press release.
Insights Care Magazine showcases companies in the healthcare and biotech industry.
BioRestorative was recognized by the magazine for its development of novel cell-based therapeutics.
"We are honored to have been recognized as one of the ten most innovative regenerative medicine companies. This is a testament to the hard work and commitment of the BioRestorative team. 2022 is all about executing and delivering our clinical plans. Our team and collaborators are all working in tandem to accomplish this goal," said Lance Alstodt, CEO of BioRestorative. "This recognition helps build awareness of our collective mission to bring novel treatments and therapies to the patients who need them most."